• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·PFE
Held by 4 Gurus
Share

Pfizer Inc. Stocks

$ 28.67Last Updated 25.09.2026

Issuer Rating

6/7
Performance

Favourable

Risk

Low

Recommendation

Buy

Market Cap

$ 162.06B

$ 28.67
Key Takeaways

Risk factor

Negligible price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Solid dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

In Guru Portfolios

Michael Burry

Portfolio Weight (%)

11.1%

Change

+11.07%

Fund

Scion Asset Management

Steven Cohen

Portfolio Weight (%)

0.1%

Change

-0.14%

Fund

Point72 Asset Management, L.P.

Kenneth Griffin

Portfolio Weight (%)

0.1%

Change

-0.03%

Fund

CITADEL ADVISORS LLC

Manager
Fund
Portfolio Weight (%)
Change
Michael BurryScion Asset Management11.1%+11.07%
Steven CohenPoint72 Asset Management, L.P.0.1%-0.14%
Kenneth GriffinCITADEL ADVISORS LLC0.1%-0.03%
Show more

Latest news

23.06.2026 15:45

Morning in New York: Chipmakers Drag Stock Indices Lower

23.06.2026 08:00

Pfizer's lung cancer drug trial has failed. What will happen to the stock?

22.06.2026 15:15

Morning in New York: Geopolitics Favors Buyers

06.02.2026 15:00

Agomab Therapeutics IPO: Pfizer and Sanofi-backed biotech starts trading

04.02.2026 15:45

Morning in New York: investors in search of a foothold

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Company Valuation

Fairly valued
4/7

Based on key historical and expected multiples, the stock is fairly valued relative to its peers. In particular, the stock is reasonably priced on P/E, of fair value on E

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of PFE is 28.4 and suggests 1.1% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to dec

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

27.09.2026 02:52

Boeing has identified a new malfunction in the 737 MAX. It could cause problems during landing

26.09.2026 18:01

I see the goal—I see no obstacles: Will AI kill us all?

26.09.2026 16:01

Small caps last week: Innodata linked to Muse, Viking data, higher rates hit segment

26.09.2026 13:01

Zuckerberg's Muse, Panic in Turkey, and How to Profit from the Decline of AI

26.09.2026 03:58

The Dow ended its three-week losing streak. Meta and Apple hit record highs.

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026